Newsroom

Categories: Healthcare, Pharma, Clinical Research & Trials

Inceptua Medicines Access and Onconova Therapeutics announce pre-approval access collaboration for rigosertib

December 9, 2019

Categories: Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Drug Discovery & Development, Pharma, Clinical Research & Trials, Corporate, Finance & Investor

Inceputua appoints new president to lead North America business development

December 5, 2019

Categories: Bioprocessing, Omics & Genetics, Biomanufacturing, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Computing & Technology, General Laboratory, Drug Discovery & Development, Analytical Chemistry, Pharma, Clinical Research & Trials

Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing

December 3, 2019

Categories: Healthcare, Pharma, Clinical Research & Trials, Corporate, Finance & Investor, Manufacturing

Inceptua and Bendalis enter into exclusive oncology medicine supply agreement for clinical trials

November 25, 2019

Categories: Bioprocessing, Biomanufacturing, Biotechnology, Healthcare, General Science, General Laboratory, Microscopy & Imaging, Drug Discovery & Development, Pharma, Corporate, Finance & Investor, Medical Devices & Technology

BioCity UK life science start-up report reveals a ‘baby boom’ of new ventures and predicts workspace proliferation

November 19, 2019

Categories: Diagnostics & Hospital Laboratory, Healthcare, General Laboratory, Drug Discovery & Development, Pharma, Clinical Research & Trials

Cells that could lead to new therapies: PromoCell now offers in vitro disease models

November 6, 2019

Categories: Biomanufacturing, Biotechnology, Research, Healthcare, General Science, Computing & Technology, Drug Discovery & Development, Pharma, Clinical Research & Trials

The increasing importance of failure in supporting modern research

September 11, 2019

Categories: Pharmacy, Healthcare, Corporate, Finance & Investor

BioCity is the latest investor to back promising 'self care' venture

September 3, 2019

Categories: Omics & Genetics, Biotechnology, Diagnostics & Hospital Laboratory, Healthcare, Microbiology & Infection Control, Pharma, Corporate, Finance & Investor, Medical Devices & Technology

GNA Biosolutions closes $13.5M series C financing round backed by a US/EU consortium

August 5, 2019